Search - tctmd.com

Displaying 821 - 840 of 1137

Sort: Relevancy | Date

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

Presentation TCT 2015

Fundamental Knowledge: Left Atrium and Left Atrial Appendage Anatomy, Function, and Relational Pathology

Presenter: Jeff Davis, Asma Hussaini

October 10, 2015

Presentation

LAA Closure: First in Man With the Fourth-Generation Watchman Device

Presenter: J. Ledwoch

September 15, 2015

Presentation CICT 2015

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Patient Selection for the Watchman Device: The European Perspective

Presenter: Horst Sievert

August 01, 2015

Presentation CICT 2015

Watchman Patient Selection: US Perspective

Presenter: Ted Feldman

July 31, 2015

Presentation

Interventional Options for Left Atrial Appendage Exclusion

Presenter: Jonathan C. Hsu

July 11, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation TVT 2015

Case Presentation: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Brij Maini

June 04, 2015

Presentation

Safety of LAA Exclusion With the Lariat Device

Presenter: S. Chatterjee

May 04, 2015

Presentation ECHO 2015

Case Presentation 73 Year Old Man with Bacteremia and Left Atrial Mass

Presenter: Fletcher A. Miller

April 27, 2015

Presentation CADECI 2015

SESIÓN V: Cierre de la orejuela izquierda en fibrilación auricular

Presenter: Dr. Homero A. Ram?rez Reyes

February 18, 2015

Presentation CADECI 2015

CIERRE DE LA OREJUELA DE AURICULA IZQUIERDA VS ANTICOAGULACION ORAL

Presenter: Dr. Joel Estrada Gallegos

February 18, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

Presenter: Ram?n L?pez M?nguez

January 14, 2015

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

Presentation

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Presenter: Vivek Y. Reddy

November 19, 2014

Presentation

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Presenter: G. Santoro

November 05, 2014

Presentation Cardiovascular Interventions 2014

Left Atrial Appendage Closure for Atrial Fibrillation

Presenter: Matthew J. Price

October 23, 2014

Presentation TCT 2014

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou

September 16, 2014

Advertisement

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Fundamental Knowledge: Left Atrium and Left Atrial Appendage Anatomy, Function, and Relational Pathology

LAA Closure: First in Man With the Fourth-Generation Watchman Device

LAA Closure with the Watchman Device: Tips & Tricks to Optimize Success

Patient Selection for the Watchman Device: The European Perspective

Watchman Patient Selection: US Perspective

Interventional Options for Left Atrial Appendage Exclusion

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Case Presentation: LAA Occlusion and TAVR

Safety of LAA Exclusion With the Lariat Device

Case Presentation 73 Year Old Man with Bacteremia and Left Atrial Mass

SESIÓN V: Cierre de la orejuela izquierda en fibrilación auricular

CIERRE DE LA OREJUELA DE AURICULA IZQUIERDA VS ANTICOAGULACION ORAL

LAA Occlusion for Stroke Prevention in A-Fib

Iberian Registry: 2-Year Clinical Outcomes After LAA Closure With the Amplatzer Device

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Left Atrial Appendage Closure for Atrial Fibrillation

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content